Stryker Co. (NYSE:SYK) is AHL Investment Management Inc.’s 9th Largest Position

AHL Investment Management Inc. cut its holdings in Stryker Co. (NYSE:SYK) by 1.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,880 shares of the medical technology company’s stock after selling 225 shares during the period. Stryker accounts for about 3.2% of AHL Investment Management Inc.’s portfolio, making the stock its 9th largest holding. AHL Investment Management Inc.’s holdings in Stryker were worth $4,637,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Edgestream Partners L.P. purchased a new position in Stryker during the second quarter worth about $369,000. AE Wealth Management LLC boosted its stake in shares of Stryker by 101.8% in the second quarter. AE Wealth Management LLC now owns 3,414 shares of the medical technology company’s stock valued at $1,162,000 after purchasing an additional 1,722 shares during the period. Pacer Advisors Inc. increased its stake in Stryker by 8.4% during the 2nd quarter. Pacer Advisors Inc. now owns 27,438 shares of the medical technology company’s stock worth $9,336,000 after buying an additional 2,122 shares during the period. Sei Investments Co. boosted its position in Stryker by 4.0% in the 2nd quarter. Sei Investments Co. now owns 168,336 shares of the medical technology company’s stock valued at $57,271,000 after buying an additional 6,443 shares during the period. Finally, Thrivent Financial for Lutherans grew its stake in shares of Stryker by 69.7% in the second quarter. Thrivent Financial for Lutherans now owns 87,244 shares of the medical technology company’s stock worth $29,685,000 after acquiring an additional 35,833 shares in the last quarter. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. StockNews.com raised Stryker from a “hold” rating to a “buy” rating in a research note on Thursday, January 9th. Truist Financial lifted their price objective on shares of Stryker from $380.00 to $409.00 and gave the stock a “hold” rating in a research report on Wednesday, December 18th. Robert W. Baird raised their price target on Stryker from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. UBS Group upped their price objective on Stryker from $366.00 to $370.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. Finally, Evercore ISI raised their target price on Stryker from $380.00 to $384.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and an average price target of $405.80.

Insider Buying and Selling at Stryker

In other Stryker news, CEO Kevin Lobo sold 57,313 shares of Stryker stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $368.70, for a total value of $21,131,303.10. Following the completion of the sale, the chief executive officer now directly owns 100,027 shares of the company’s stock, valued at approximately $36,879,954.90. The trade was a 36.43 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 5.50% of the stock is owned by insiders.

Stryker Trading Up 0.6 %

NYSE:SYK opened at $383.91 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.22 and a current ratio of 1.91. Stryker Co. has a 1 year low of $307.23 and a 1 year high of $398.20. The stock has a market capitalization of $146.35 billion, a price-to-earnings ratio of 41.15, a PEG ratio of 2.51 and a beta of 0.95. The stock has a fifty day moving average price of $375.51 and a two-hundred day moving average price of $358.98.

Stryker (NYSE:SYK) last issued its earnings results on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.77 by $0.10. The company had revenue of $5.49 billion for the quarter, compared to analyst estimates of $5.37 billion. Stryker had a net margin of 16.34% and a return on equity of 23.07%. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the prior year, the business posted $2.46 earnings per share. As a group, sell-side analysts anticipate that Stryker Co. will post 12.06 earnings per share for the current fiscal year.

Stryker Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.88%. This is a positive change from Stryker’s previous quarterly dividend of $0.80. Stryker’s dividend payout ratio is presently 36.01%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.